Global Blood Therapeutics (GBT), a biopharmaceutical company, was growing rapidly and anticipated intense compute demands with a new genomics group coming on board. The company needed to migrate out of a local data center and gain the scalability and limitless capacity of the public cloud. Learn how Navisite helped migrate GBT’s high-performance workloads to AWS and continues to provide ongoing cloud optimization and DevOps services.
Download this case study to learn:
- Why GBT chose to work with Navisite for the migration to AWS
- How Navisite worked with GBT to architect and support a phased migration
- How Navisite is supporting GBT today with DevOps and cloud optimization